References
- Gupta R., Lister T. Current management of follicular lymphoma. Curr. Op. Oncol. 1996; 8(5)360–5
- Johnson P., Rohatiner A., et al. Patterns of survival in patients with recurrent follicular lymphoma: a 20 year study from a single center. J. Clin. Oncol. 1995; 13: 160–7
- Bush R., Gospodarowicz M. The place of radiation therapy in the management of patients with localized non-Hodgkin's lymphoma. Malignant lymphomas. Academic Press, New York 1982; 485
- McManus M., Hoppe R. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J. Clin. Oncol. 1996; 14: 1282
- Hermans J., Krol A., et al. International Prognostic Index for aggresive non-Hodgkin's lymphoma is valid for all malignancy grades. Blood 1995; 86: 1460–63
- Bastion Y., Berger E, et al. Follicular lymphomas: assessment of prognostic factors and response to treatment of 127 patients followed for 10 years. Ann. Oncol. 1991; 2(s2)123–9
- Nissen N., Ersboll J., et al. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphoma. Cancer 1983; 52: 1–7
- Yahalom J., Varsos G., et al. Adjuvant cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin's lymphoma. Cancer 1993; 71: 2342–50
- Besa P., McLaughlin P., et al. Long term assesment of patterns of treatment failure and survival in patients with stage I and II follicular lymphoma. Cancer 1995; 75: 2361–7
- Horning S., Rosenberg S. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N. Engl. J. Med. 1984; 311: 1471–5
- Horning S. Natural history of and therapy for the indolent non-Hodgkin's lymphomas. Semin. Oncol. 1993; 20(s5)75–88
- Young R., Longo D., et al. The treatment of indolent lymphomas: watchful waiting versus aggresive combined modality treatment. Semin. Hematol. 1988; 25(s2)11–16
- Solal-Celigny P. Management of histologically indolent non-Hodgkin's lymphomas. Baillieres-Clin-Haematol. 1996; 9(4)669–87